ZBZilya F. Badrieva

Zilya F. Badrieva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zilya F. Badrieva has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Gadolinium-doped carbon dots with long-wavelength emission for dual-modal imaging

    by Arina A. Efimova, Zilya F. Badrieva, Ekaterina A. Brui, Mikhail D. Miruschenko, Ivan A. Aleinik, Alexander M. Mitroshin, Olga V. Volina, Aleksandra V. Koroleva, Evgeniy V. Zhizhin, Evgeniia A. Stepanidenko, et al.

    Subject of study. This study is focused on luminescent carbon dots derived from o-phenylenediamine and gadolinium chloride or nitrate hexahydrate. Aim of study. The study aims to fabricate long-wavelength photoluminescent gadolinium-doped carbon dots that could function as contrast agents for magnetic resonance imaging. Additionally, the study investigates the impact of the precursor type used on the chemical composition and optical transitions of the resulting nanoparticles. Method. Carbon dots were synthesized using a one-step solvothermal method, and their composition and optical properties were analyzed using spectroscopy methods. Magnetic resonance imaging was conducted using a clinical magnetic resonance imaging scanner with a field strength of 1.5 T. Main results. In this study, two types of carbon dots were synthesized from o-phenylenediamine and gadolinium chloride or nitrate hexahydrate using the solvothermal method. Metal doping, at a concentration sufficient for further investigations, is achieved only when gadolinium chloride is used. Additionally, the presence of gadolinium chloride during the synthesis leads to the formation of luminescent centers within the carbon dots with emission at 600–720 nm and a photoluminescence quantum yield of 6.3%. In contrast, gadolinium nitrate increases the nitrogen content within the o-phenylenediamine-based carbon dots while inhibiting metal doping. The luminescent band with an emission maximum at 550 nm and a photoluminescence quantum yield of 7.4% originates from the o-phenylenediamine derivatives formed within such carbon dots. The study results also show that the gadolinium-doped carbon dots alter the relaxation times during magnetic resonance scanning, and the calculated relaxivity (r1 and r2) values are 6.4 and 38.6L⋅mmol−1⋅s−1, respectively. Thus, the synthesized carbon dots function as positive contrast agents during magnetic resonance scanning. Practical significance. Carbon dots with long-wavelength emission are promising nanoprobes for luminescence imaging. With gadolinium doping, these nanoparticles can also be used as contrast agents during magnetic resonance imaging. Consequently, carbon dots based on o-phenylenediamine and gadolinium chloride hexahydrate can be further utilized as dual-mode nanoprobes for bioimaging.

  • Open Access

    MSCT and MRI indicators for assessing iron overload and the effectiveness of iron overload therapy in patients with primary and secondary hemochromatoses

    by A. M. Titova, V. A. Fokin, G. E. Trufanov, M. A. Zubkov, A. V. Nikitina, R. R. Mironchuk, M. V. Mironchuk, N. V. Tsvetkova, K. S. Shalygina, L. E. Galyautdinova, et al.

    Goal of research. Evaluation of MRI, CT parameters after chelation and hemoexfusion therapy in patients with iron overload, identification of the prognostic value of CT indicators in the assessment of moderate and severe iron overload. Materials and methods. The design of the study is prospective. The study included 43 patients with hereditary hemochromatosis (HH), secondary transfusion-dependent hemochromatosis (TDH) receiving regular hemotransfusions, iron chelators. We evaluated age, frequency of hemotransfusions, chelating drug used. CT was performed on a two-energy computer tomograph Siemens Somatom Definition 128. 27 patients (62.8%) reached repeated CT. MRI was performed on a Siemens Magnetom Espee high-field tomograph with a magnetic field induction of 1.5 T. Results. The median age was 34.00 [33.00; 53.50] for HH and 52 [36.00; 62.00] for TDH. After therapy in the general group, T2* values increased by 26%, LIC decreased by 21.2%, DEDHU 140 and 80 mean by 17.6%, DERHU 140 and 80 mean by 3%, DEIHU 140 and 80 mean by 92.8%, 80 max by 3%, DEDHU 140 and 80 max by 19%, DERHU 140 and 80 max by 2.5% after therapy. In patients with HH, liver T2* increased by 4.6 times, LIC decreased by 5.5 times, DEDHU 140 and 80 mean by 35.1%, DERHU 140 and 80 mean by 7.8%, DEIHU 140 and 80 mean by 93.6%, DEDHU 140 and 80 max by 29.3%, DEIHU 140 and 80 max by 21.6%. In patients with TDH, LIC decreased by 18.9%, DEIHU 140 and 80 mean by 92.2%. A value of 80 mean ≥ 85.5, 140 mean ≥ 71.5, M0.3 mean ≥ 76, DEIHU 140 and 80 mean ≥ 0.007996 and DEDHU 140 and 80 mean ≥ 18.5 predict the probability of severe iron overload. Conclusion. In patients after chelation therapy and hemoexfusion therapy, MRI and CT indicators decrease. The values of CT 80 mean ≥ 85.5, 140 mean ≥ 71.5, M0.3 mean ≥ 76, DEIHU 140 and 80 mean ≥ 0.007996, DEDHU 140 and 80 mean ≥ 18.5 can predict LIC values of more than 11 mg/g.

  • Open Access

    Manganese-Doped Carbon Dots as a Promising Nanoprobe for Luminescent and Magnetic Resonance Imaging

    by Evgeniia A. Stepanidenko, Anna A. Vedernikova, Zilya F. Badrieva, Ekaterina A. Brui, Saikho O. Ondar, Mikhail D. Miruschenko, Olga V. Volina, Aleksandra V. Koroleva, Evgeniy V. Zhizhin, Elena V. Ushakova

    Luminescent carbon nanodots (CDs) are a low-toxic nanomaterial with a tunable emission in a wide spectral range and with various functional groups on the surface. Therefore, CDs can prospectively serve as luminescent nanoprobes for biomedical applications, such as drug-delivery, visualization, sensing, etc. The doping of CDs with paramagnetic or transition metals allows the expansion of the range of applications of CDs and the fabrication of a multimodal nanoprobe for bioimaging. Here, we developed CDs doped with manganese (Mn) based on commonly used precursors—o-phenylenediamine or citric acid and formamide. The chemical structure, morphology, optical properties, and magnetic resonance responses have been carefully studied. The obtained CDs are up to 10 nm, with emissions observed in the 400–650 nm spectral region. CDs exhibit an ability to reduce both T1 and T2 relaxation times by up to 6.4% and 42.3%, respectively. The high relaxivity values suggest the use of CDs as promising dual-mode contrast agents for T1 and T2 MRI. Therefore, our developed CDs can be utilized as a new multifunctional nanoscale probe for photoluminescent and magnetic resonance bioimaging.